Managed Network Services: USD 304.03B in 2023 to USD 849.19B by 2031No. 6 Houston faces No. 9 Alabama in a men’s college basketball game on Tuesday, Nov. 26, 2024, (11/26/24) at Grand Garden Arena in Paradise, Nevada. How to watch: Fans can watch the game for free via DirecTV Stream or via a subscription to Sling TV , which is 50% off the first month. Here’s what you need to know: What: Men’s college basketball Who: Houston vs. Alabama When: Tuesday, Nov. 26, 2024 (11/26/2024) Where: MGM Grand Garden Arena Time: 8 p.m. ET TV: TBS Live Stream: DirecTV Stream AP Story: Eight of the nation’s premier basketball programs are descending on Las Vegas during the traditional Thanksgiving tournament week for a unique event where real money for their school’s name, image and likeness collectives is riding on the outcome. Welcome to a brave new world for college hoops. The three-day Players Era Festival, tipping off Tuesday and organized by RedBird IMI-backed EverWonder Studios, is reimagining old-school holiday tournaments. Every school participating will receive at least $1 million for their NIL collective , with bonuses of $500,000 to the champion, $250,000 to the runner-up, $150,000 for third place and $100,000 for finishing in fourth. “When we launched Players Era, we knew that it had the ability to drive a positive shift in the college basketball landscape, and we’re seeing that vision come to life as we get ready to tip off next week,” the event’s CEO, Seth Berger, said in a statement. “Everything we do is about delivering value to the players,” Berger continued, ”and our guiding principles continue to be paying the players fair market value for their NIL and creating captivating content for fans.” Fair market value comes to a hefty tab of $9 million in payouts to the participating schools. The lucrative proposition has resulted in a stacked field for the round-robin format at the MGM Grand Garden Arena. San Diego State faces No. 21 Creighton , Oregon plays No. 20 Texas A&M, sixth-ranked Houston faces No. 9 Alabama and Rutgers plays Notre Dame on Tuesday. Each team plays another opponent Wednesday. Those results along with point differentials — capped at 20 points per game — are used to set Saturday’s championship and consolation games. The financials aside, the Players Era Festival features some heavyweight matchups of national title contenders. The Bluejays are led by All-American candidate Ryan Kalkbrenner, the Cougars and Crimson Tide — whose opening game is must-see TV — are March darlings, while Texas A&M is among nine SEC programs ranked in this week’s AP Top 25 . “There’s a lot of silliness out there asking if we can win a national championship. How would I know?” Houston coach Kelvin Sampson said. “Do you understand what a bad call does to a team, or a missed free throw or a sprained ankle? That’s why you don’t ever focus on the destination. You take pride and joy in going through the journey. However it ends up, it ends up, but don’t ever judge your season on how you finish. Judge it on how hard you tried and did you do the best you could.” The Maui Invitational is celebrating its ruby jubilee back in Lahaina , after the wildfires last year forced its relocation, and began Monday with another loaded field. Fourth-ranked Auburn faced No. 5 Iowa State in an opening round that also featured second-ranked UConn against Memphis, Colorado against Michigan State and Dayton against No. 12 North Carolina. The tournament continues with semifinals Tuesday and the championship game Wednesday. Top-ranked Kansas, led by All-American center Hunter Dickinson, takes on Cooper Flagg and No. 11 Duke on Tuesday night in the Vegas Showdown. Kansas already has beaten the Tar Heels in a thriller at Allen Fieldhouse and Michigan State in the Champions Classic, while the Blue Devils have lost to No. 8 Kentucky but are coming off a win over then-No. 17 Arizona. The ballroom is staged once against at Atlantis Paradise Island for one of the most unique holiday tournaments of Thanksgiving week. Third-ranked Gonzaga, No. 14 Indiana and No. 21 Arizona are the headliners in the eight-team Battle 4 Atlantis, which tips off Wednesday and continues with semifinals Thursday and the championship game Friday. No. 18 Florida should have a de facto home-court advantage when it joins Minnesota, Wichita State and Wake Forest for the ESPN Events Invitational at Walt Disney World Resort. The Rady Children’s Invitational also tips off Thursday in San Diego with No. 13 Purdue playing NC State and No. 23 Ole Miss facing BYU, while No. 19 Arkansas plays Illinois in the Thanksgiving Hoops Showcase at the T-Mobile Center in Kansas City, Missouri. MORE SPORTS COVERAGE One day after Hurley’s meltdown, No. 2 UConn loses again Milwaukee Bucks vs. Miami Heat FREE LIVE STREAM (11/26/24): Watch NBA regular season game | Time, TV, Channel Giants’ Malik Nabers walks back (and doubles down on) fiery postgame comments after Bucs loss What channel is the Los Angeles Lakers vs. Phoenix Suns game tonight (11/26/24)? FREE LIVE STREAM, Time, TV, Channel for NBA regular season Western Kentucky vs. Kentucky FREE LIVE STREAM (11/26/24): Watch college basketball online: Time, TV, Channel
Topline Shares of information technology firm Super Micro Computer closed up nearly 30% on Monday after the company said an independent committee found “no evidence of fraud or misconduct”—after a rocky 2024 marked by governance concerns raised by a former auditor and other alleged accounting issues . Key Facts Get Forbes Breaking News Text Alerts : We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here. What To Watch For Super Micro is also facing a potential delisting from the Nasdaq in the wake of its delayed financial reports. The company did not file its annual report by its August due date and was sent a non-compliance letter from Nasdaq not long after. Super Micro also delayed the filing of its September quarterly report, though it said in a statement it believes it will submit the annual and quarterly filing within the Nasdaq’s discretionary period (Super Micro recently requested an extension to regain compliance). Key Background Super Micro—which manufactures servers and IT products, including equipment used for artificial intelligence—has experienced a bumpy 2024. The company’s stock peaked in March at $118.81, an all-time high, and cratered to as low as $18 in November. Investors began selling Super Micro shares after the company said in August it was not going to file its annual report on time. The company also faced pressure from short-selling firm Hindenburg Research, which claimed it found “ glaring accounting red flags , evidence of undisclosed related party transactions, sanctions and export control failures, and customer issues.” However, JPMorgan analysts noted some of the accusations levied by Hindenburg were “tough to verify,” noting their report was "largely void of details around alleged wrongdoings from the company,” according to CNBC . Super Micro denied the allegations. The company was also reportedly the subject of a Justice Department investigation for alleged accounting violations raised by a former Super Micro employee, according to The Wall Street Journal. Further Reading Super Micro Computer Shares Plummet Over 20% After Delayed Annual Report, Short-Sellers’ Allegations (Forbes) Justice Department Probes Server Maker Super Micro Computer (Forbes)China reiterates support to Sri LankaWATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference being held in New York on December 3-5, 2024. For more information regarding one-on-one meetings, please contact your Piper Sandler representative. The live webcast can also be accessed under “ Events & Presentations ” on the Investors section of the Tectonic website at www.tectonictx.com . Once the conference has concluded, a replay of the webcast will be available on the Company’s website for approximately 90 days. About Tectonic Tectonic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its proprietary GEODeTM (GPCRs Engineered for Optimal Discovery) technology platform, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow on LinkedIn . Investors: Dan Ferry LifeSci Advisors daniel@lifesciadvisors.com (617) 430-7576 Media: Kathryn Morris The Yates Network kathryn@theyatesnetwork.com (914) 204-6412
NoneJames Jones on the Chicago Bears' clock management on their final play and whether Caleb Williams, Matt Eberflus or other players are to blame. The Bears lost 23-20 to the Detroit Lions and dropped to 4-8. Despite becoming the first head coach in Chicago Bears history to be fired midseason, Matt Eberflus had kind words for the organization after his dismissal Friday. Eberflus was sacked after the Bears' disastrous loss to the Detroit Lions Thanksgiving Day. On Friday morning, he met with reporters, expressing his belief that he would remain head coach and that he was focused on the team’s Week 13 matchup against the San Francisco 49ers. Chicago Bears head coach Matt Eberflus talks to the media after a game against the Detroit Lions in Detroit Thursday, Nov. 28, 2024. (AP Photo/Carlos Osorio) Just hours later, Eberflus was fired. CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM "This morning, after meeting with [Chairman] George [H. McCaskey] and [President and CEO] Kevin [Warren], we informed Matt of our decision to move in a different direction with the leadership of our football team and the head coaching position," Bears general manager Ryan Poles said in a statement. "I thank Matt for his hard work, professionalism and dedication to our organization. We extend our gratitude for his commitment to the Chicago Bears and wish him and his family the best moving forward." Some on social media called out the Bears for the timing of Eberflus’ firing following his comments about planning for the 49ers , but the coach released a statement Saturday expressing his "heartfelt gratitude." Chicago Bears quarterback Caleb Williams (18) talks with head coach Matt Eberflus during the second half of a game in Detroit Thursday, Nov. 28, 2024. (AP Photo/Duane Burleson) BEARS SACK HEAD COACH MATT EBERFLUS AFTER THANKSGIVING DAY LOSS IN FIRST-EVER MIDSEASON FIRING "I would like to thank the McCaskey family and Ryan Poles for the opportunity to be the head coach of the Chicago Bears. "I want to express my heartfelt gratitude to the players for all of their effort, dedication and resilience. In every situation — practice, games and especially in the face of adversity — you stayed together and gave great effort for your team and each other." Eberflus also thanked the fan base for its "support and passion" and left his players with kind words. Chicago Bears head coach Matt Eberflus during a game against the Detroit Lions Thanksgiving Day in Detroit Thursday, Nov. 28, 2024. (Amy Lemus/NurPhoto via Getty Images) CLICK HERE TO GET THE FOX NEWS APP "What I am most proud of was the way you carried yourself both on and off the field and represented the Bears organization with class in the community." Eberflus leaves the Bears with a 14-32 record, and Chicago becomes the third NFL team this season to fire a head coach. Follow Fox News Digital’s sports coverage on X , and subscribe to the Fox News Sports Huddle newsletter . Paulina Dedaj is a Sports Reporter for Fox News Digital.nCino to Participate in Upcoming Investor Conferences
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuardTM Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors. Mr. Ward most recently served as Chief Executive Officer and President of Cardiovascular Systems, Inc. prior to its acquisition by Abbott (NYSE: ABT) in April 2023. Paul Stuka, Chairman of the Board of InspireMD, stated, “We are extremely fortunate to add Scott to what I consider to be a world-class Board of Directors. With his extensive operational experience and track record in the cardiovascular space, his insights will be invaluable as the Company rapidly approaches potential U.S. approval of CGuard Prime, the most significant value inflection point in its history. I look forward to Scott’s contributions and believe he will have an immediate impact.” Marvin Slosman, Chief Executive Officer of InspireMD and Board member, commented, “The addition of Scott to our Board adds tremendous experience in the cardiovascular field, with a track record of growth and innovation as an executive, a board member and investor. His experience and legacy in the space will help guide us through our next stages of advancing our novel carotid platform as part of a comprehensive approach to catalyzing on the market shift toward a stent first standard while also guiding our pipeline of innovation, including our CAS, TCAR and Neuro focus.” “I am very excited to join the InspireMD Board at such a transformational time for the company,” added Mr. Ward. “With an impressive body of data demonstrating the superior short- and long-term patient outcomes of its novel CGuard Prime carotid stent system, I believe that CGuard, when approved in the U.S., will quickly become a new standard-of-care for carotid intervention and stroke prevention. I look forward to working with my fellow Board members and the InspireMD leadership team to achieve this goal.” Mr. Ward has over 40 years of experience in the healthcare industry, including nearly 30 years at Medtronic, Inc. where he served in various leadership roles including as Senior Vice President and President of the CardioVascular, Neurological and Diabetes businesses. Mr. Ward is the Founder of Raymond Holdings, a firm with activities in venture capital, strategy and transactional advisory services for medical technology and life science companies. He earned his Bachelor of Science in Genetics and Cell Biology, his Master of Science in Toxicology, and his Master of Business Administration, all from the University of Minnesota. About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet ® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com . Forward-looking Statements This press release contains “forward-looking statements.” Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential”, “scheduled” or similar words. Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team’s or directors’ expectations, hopes, beliefs, intentions or strategies regarding future events, future financial performance, strategies, expectations, competitive environment and regulation, including potential U.S. commercial launch.. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the company’s control, and cannot be predicted or quantified and consequently; actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with our history of recurring losses and negative cash flows from operating activities, significant future commitments and the uncertainty regarding the adequacy of our liquidity to pursue our complete business objectives, and substantial doubt regarding our ability to continue as a going concern; our need to raise additional capital to meet our business requirements in the future and such capital raising may be costly or difficult to obtain and could dilute our stockholders’ ownership interests; market acceptance of our products; an inability to secure and maintain regulatory approvals for the sale of our products; negative clinical trial results or lengthy product delays in key markets; our ability to maintain compliance with the Nasdaq listing standards; our ability to generate revenues from our products and obtain and maintain regulatory approvals for our products; our ability to adequately protect our intellectual property; our dependence on a single manufacturing facility and our ability to comply with stringent manufacturing quality standards and to increase production as necessary; the risk that the data collected from our current and planned clinical trials may not be sufficient to demonstrate that our technology is an attractive alternative to other procedures and products; intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; entry of new competitors and products and potential technological obsolescence of our products; inability to carry out research, development and commercialization plans; loss of a key customer or supplier; technical problems with our research and products and potential product liability claims; product malfunctions; price increases for supplies and components; insufficient or inadequate reimbursement by governmental and other third-party payers for our products; our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful; adverse federal, state and local government regulation, in the United States, Europe or Israel and other foreign jurisdictions; the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction; the escalation of hostilities in Israel, which could impair our ability to manufacture our products; and current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. Investor Contacts: Craig Shore Chief Financial Officer InspireMD, Inc. 888-776-6804 craigs@inspiremd.com Chuck Padala, Managing Director LifeSci Advisors 646-627-8390 chuck@lifesciadvisors.com investor-relations@inspiremd.com
Can Goodreads Be Redeemed?Sarah Boone was sentenced to life in prison in an Orlando courtroom Monday afternoon for suffocating her boyfriend in a suitcase, bringing a nearly five-year legal saga to a close — for now. The sentence was handed down by Orange County Circuit Court Judge Michael Kraynick, who could have given Boone a minimum of 221⁄2 years for her second-degree murder conviction, at the end of a nearly two-hour hearing. Before the sentence was announced, Boone spent nearly 20 minutes addressing the court, saying the ordeal had renewed her faith in God. She said she blames herself for not ending her relationship with Torres sooner when he mistreated her, but that she still loves Torres and will see him again in the next life. She begged forgiveness from his family, who sat in the front row of the courtroom. “I think of him every day and still speak to him when alone in the rec yard,” Boone said. “I ask his forgiveness and that he looks for me at the gates of heaven so I can tell him how sorry I am endlessly and that I never stopped loving him.” Boone, 47, was convicted on Oct. 25 by a jury of five women and one man after about 90 minutes of deliberations. Boone initially told police Torres, 42, died the night of Feb. 23, 2020, in their Winter Park residence as a result of a drunken game of hide-and-seek gone horribly wrong. But her defense team later argued that she was an abused woman suffering from Battered Spouse Syndrome and killed Torres in self-defense. The trial delved deeply into Boone’s personal life, showing her often violent relationship with Torres as well as their frequent consumption of alcohol, which was described as central to their lives. At one point in her address Monday, Boone appeared to blame Torres’ family, causing Jorge’s mother and sister to temporarily leave the courtroom. “I also forgive the Torres family, his mother and father, foremost, also his two ex-wives, and daughters, all for knowing who Jorge was, capable of and had done in the past, his history of violence and where he learned it, then keep turning a blind eye when I would ask for help,” she aid. She also blamed the Internet, social media, online content creators and the media for making her a pariah. Prosecutor Dave Cacciatore Jr. said the lack of responsibility or remorse from Boone meant she didn’t deserve a lesser sentence. Torres’ mother, sister and daughter all spoke about how his death had impacted them. Family members of Jorge Torres, Jr. react at the sentencing of Sarah Boone in a courtroom of the Orange County Courthouse in Orlando, Florida, on Monday, December 2, 2024. Boone was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) Sarah Boone, convicted of second-degree murder in the suffocation death of her boyfriend inside a suitcase in 2020, was sentenced Monday to life in prison. The stiff sentence capped a near-five-year legal saga in which Boone went through nine attorneys and proceedings were delayed 16 times. She had rejected a 15-year plea deal prior to trial. Read the story at OrlandoSentinel.com or in the News Extra section of today's e-edition. (Stephen M. Dowell/Orlando Sentinel) Sarah Boone takes a seat as she takes the stand to read from a prepared letter during a sentencing hearing at the Orange County Courthouse in Orlando, Florida, on Monday, Dec. 2, 2024. Boone was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) Judge Michael Kraynick hands down a sentence of life in prison during a sentencing hearing for Sarah Boone at the Orange County Courthouse in Orlando, Florida, on Monday, Dec. 2, 2024. Boone was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) Sarah Boone makes an expression as she answers a question during her sentencing hearing at the Orange County Courthouse in Orlando, Florida, on Monday, Dec. 2, 2024. She was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) Sarah Boone, left, carries a prepared letter that she read to the court during her sentencing hearing at the Orange County Courthouse in Orlando, Florida, on Monday, Dec. 2, 2024. She was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) Sarah Boone takes the stand to read a prepared letter during a sentencing hearing at the Orange County Courthouse in Orlando, Florida, on Monday, Dec. 2, 2024. She was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) Family members of Jorge Torres, Jr. react at the sentencing of Sarah Boone in a courtroom of the Orange County Courthouse in Orlando, Florida, on Monday, December 2, 2024. Boone was sentenced to life in prison for murdering her boyfriend, Jorge Torres, Jr., in 2020 by suffocating him in a suitcase. (Stephen M. Dowell/Orlando Sentinel) His sister, Victoria, said that even five years later she still can’t shut a suitcase the entire way. His daughter, Anna, said she now has anxiety and depression, and her younger brother still wonders when he will see their father again. “Real love is missing. Sometimes when I look out the window, I’m waiting for him to come and say, ‘Mom, I love you,'” Torres’ mother said tearfully. Victoria and her mother embraced when Boone’s life sentence was announced. Several people spoke in Boone’s defense, including Diane Smith, a chaplain at the Orange County Jail, who said Boone enrolled in a Christian program there and has worked to do better over the past four years, including as a mentor to younger inmates. Boone’s bunkmate for about three years, Christina Piña, said she has been like a big sister to her. “[When] anybody need any help, or needed anything, they come to her, and even if they did wrong she would still go back and help them, and pray with them, and pray over them and everything,” she said. Lana Albert, a friend suffering from end-stage renal disease who Boone met online while in jail, appeared by Zoom from Minnesota to say that Boone offered to donate her a kidney. Boone’s attorney, James Owens, argued that Kraynick should give Boone less than the minimum 221⁄2 years for reasons including her mental illness. Forensic psychologist Dr. Julie Harper testified that the untimely death of Boone’s father when she was in high school affected her ability to form healthy relationships. Kraynick said an appellate attorney will be appointed for Boone. Owens says he believes there are good grounds for appeal and is meeting with Boone on Tuesday to discuss if they should file one. He is open to returning as Boone’s attorney if the appeals court grants her a new trial. She must appeal within 30 days.